1.Kimura H, Mittal CK, Murad F. Increases in cyclic GMP levels in brain and liver with sodium azide, an activator of guanylate cyclase. Nature 1975; 257: 700-2.
2.Katsuki S, Murad F. Regulation of adenosine cyclic 3’,5’-monophosphate and guanosine 3’,5’-monophosphate levels and contractility in bovine tracheal smooth muscle. Molecular Pharmacology 1977; 13: 330.
3.Katsuki S, Arnold PW, Murad F. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. Journal of Cyclic Nucleotide and Protein Phosphorylation Research 1977; 3: 239-47.
4.Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine-3’,5’-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977; 74: 3203-7.
5.Gerzer R, Bohme E, Hofmann F, Schultz C. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 1981; 132: 71-4.
6.Ignarro LJ, Wood K, Wolin M. Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Advances in Cyclic Nucleotide and Protein Phosphorylation Research 1984; 17: 267-74.
7.Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986; 78: 1-5.
8.Murad F. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA 1996; 276: 1189-92.
9.Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
10.Furchgott RF, Zawadski JV, Cherry PD. Role of endothelium in the vasodilator response to acetylcholine. In: Vanhoutte PM, Leusen I, eds. Vasodilation. New York: Raven Press, 1981: 44-6.
11.Rapoport RM, Murad F. Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ Res 1983; 52: 352-7.
12.Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrateinduced relaxation by hemoglobin and by methylene blue in rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-16.
13.Ignarro LJ, Byrns RE, Wood KS. Pharmacological and biochemical properties of endothelium-derived relaxant factor (EDRF): Evidence that EDRF is closely related to nitric oxide (NO) radical. Circulation 1986; 74: II-287.
14.Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor (EDRF) released from artery and vein appears to be nitric oxide (NO) or a closely related radical species. Federation Proceedings 1987; 46: 644.
15.Furchgott RF, Khan MT, Jothianandan D. Comparison of endothelium-dependent relaxation and nitric oxide-induced relaxation
in rabbit aorta. Federation Proceedings 1987; 46: 385.
16.Khan MT, Furchgott RF. Similarities of behavior of nitric oxide (NO) and endothelium-derived relaxing factor in a perfusion cascade bioassay system. Federation Proceedings 1987; 46: 385.
17.Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9.
18.Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-79.
19.Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Vasodilation. New York: Raven Press, 1988: 401-14.
20.Palmer R, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
21.Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deaminase activity and imino nitrogen oxidation to nitrite. Science 1987; 235: 473-6.
22.Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
23.Palmer R, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
24.Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2009-12.
25.Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-8.
26.Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-8.
27.Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 1992; 89: 6348-52.
28.Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M et al. Purification and characterization of EDRF particulate synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1991; 88: 104804.
29.Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092-6.
30.Andersson KE, Garcia-Pascual A, Forman A, Töttrup A. Non-adrenergic non-cholinergic nerve-mediated relaxation of rabbit urethra is caused by nitric oxide. Acta Physiol Scand 1991; 141: 133-4.
31.Wennmalm Å, Benthin G, Edlund A, Jungersten L, Kieler JN, Lundin S et al. Metabolism and excretion of nitric oxide in humans. Circ Res 1993; 73: 1121-7.
32.Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-92.
33.Hansson GK, Geng YJ, Holm J, Hårdhammar P, Wennmalm Å, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994; 180: 733-8.
34.Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75: 77-85.
35.Schedin U, Norman M, Gustafsson LE, Jonsson B, Frostell C. Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 1997; 86: 122935.
36.Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 136870.
37.Geng YJ, Hellstrand K, Wennmalm Å, Hansson GK. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to interferon-γ and tumor necrosis factor-α. Cancer Res 1996; 56: 866-74.